Hematological Malignancies

Relative risks of SMN by age at HL diagnosis • International cohort study: 32,591 HL patients • 1,111 25-years survivors, population-based

10,0 12,0 14,0 16,0

10,0 15,0 20,0 25,0 30,0 35,0 4 ,0 45,0

Age (yrs)

<21 21-30 31-40 41-50 51-60 >=61

<21 21-30 31-40 41-50 51-60 >=61

0,0 2,0 4,0 6,0 8,0

Relative Risk

Relative Risk

0,0 5,0

All solid

Breast Breast

Lung

GI tract

ANLL

All solid

Lung

GI tract